Bio‐Nano Innovations Targeting the Neurovascular Complex for Epilepsy Treatment
Advanced Healthcare Materials · 2025-05 · 14 (14)
DOI: 10.1002/adhm.202404857 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 30.04.2025. Verfasst von Xin Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Fifth People's Hospital, School of Pharmacy, MOE Key Laboratory of Smart Drug Delivery, MOE Innovative Center for New Drug Development of Im…. Hauptthemen laut MEDLINE: Epilepsy, Drug Delivery Systems, Nanotechnology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 166 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Rising-Star Program, Shanghai Key Laboratory of Molecular Imaging.
Abstract (Originalsprache)
Epilepsy is a prevalent chronic neurological disorder characterized by seizures resulting from an imbalance between excitatory and inhibitory neurons. While pharmacotherapy remains the standard treatment, traditional pharmacotherapy faces significant challenges, including poor brain penetration, high drug resistance rates, and providing only symptomatic relief, rather than addressing the underlying causes for a comprehensive cure. Recently, the neurovascular complex (NVC) has gained attention for its critical role in the development and progression of epilepsy. Simultaneously, various innovative bio‐nanotechnology systems have emerged, specifically designed to enhance drug delivery across the brain and enable precise targeting within the lesion. Herein, this review begins by outlining the core NVC involved in epilepsy treatment, breaking it down into four key components: the blood‐brain barrier (BBB), neurons, glial cells, and the microenvironment. The viability of targeting NVC to improve epilepsy therapy is analyzed. Next, innovative bio‐nanotechnology systems, detailing their design principles, construction strategies, and preclinical evaluations in epilepsy therapy are highlighted. Finally, the prospects for next‐generation nanotechnologies and the challenges that must be overcome for effective clinical translation are discussed. Overall, this review aims to guide the development of more efficient and precise bio‐nano therapies, ultimately enhancing treatment outcomes for epilepsy patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Fifth People's Hospital, School of Pharmacy, MOE Key Laboratory of Smart Drug Delivery, MOE Innovative Center for New Drug Development of Immune Inflammatory Diseases, Fudan University, Shanghai, 201203, China.
- The Key Laboratory of Biomedical Imaging Science and System, Chinese Academy of Sciences, State Key Laboratory of Biomedical Imaging Science and System, Shenzhen, 518055, China.
- Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.
ORCID-Profile: Cong Wang
Förderung
- National Natural Science Foundation of China
- Shanghai Rising-Star Program
- Shanghai Key Laboratory of Molecular Imaging
- National Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers
- National Key Research and Development Program of China
- Greater Bay Area Institute of Precision Medicine (Guangzhou)
Zitieren
APA
Wang, X., Cheng, Y., Qi, Z., Zhao, J., & Wang, C. (2025). Bio‐Nano Innovations Targeting the Neurovascular Complex for Epilepsy Treatment. Advanced Healthcare Materials, 14(14). https://doi.org/10.1002/adhm.202404857
Vancouver
Wang X, Cheng Y, Qi Z, Zhao J, Wang C. Bio‐Nano Innovations Targeting the Neurovascular Complex for Epilepsy Treatment. Advanced Healthcare Materials. 2025;14(14). doi:10.1002/adhm.202404857
BibTeX
@article{Wang2025,
author = {Wang, Xin and Cheng, Yanlong and Qi, Zhengzhuo and Zhao, Jing and Wang, Cong},
title = {Bio‐Nano Innovations Targeting the Neurovascular Complex for Epilepsy Treatment},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {14},
doi = {10.1002/adhm.202404857}
}
EUVIMED